GlassScriptPhysician profile
Nisha Bhika
NPI 1639632318
$4,208.94
in general payments reported to CMS, 2019-2025
36 companies · $960 in 2025
The $960 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.48 · 2022: $758 · 2023: $874 · 2024: $1,601 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,434.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,251.40 | 2022-2025 | |
| Novo Nordisk INC | $593.35 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $244.71 | 2022-2025 | Repatha, Otezla, Evenity |
| Abbott Laboratories | $211.67 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Astrazeneca Pharmaceuticals LP | $172.95 | 2022-2025 | Farxiga, Breztri |
| Corium, LLC | $156.35 | 2022-2023 | Azstarys |
| Madrigal Pharmaceuticals | $124.23 | 2024-2025 | Resmetirom, Rezdiffra |
| Lilly USA, LLC | $116.97 | 2022-2024 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $102.58 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.74 | 2022-2025 | Xifaxan, Trulance |
| Axsome Therapeutics, INC. | $96.46 | 2023-2024 | Auvelity |
| Tris Pharma INC | $91.69 | 2022-2023 | Dyanavel Xr |
| Inspire Medical Systems, INC. | $89.24 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $85.51 | 2022-2025 | |
| Dexcom, INC. | $72.58 | 2022-2024 | Dexcom G6 Transmitter |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Bhika listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.